Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00440_DB00554_nanopub.RA52n4kktl2h6byV7Vnnvra_J9Im-wUnajlgAzmH21XDo#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00440_DB00554 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00440_DB00554 label "DDI between Trimethoprim and Piroxicam - The strong CYP2C9 inhibitor, Piroxicam, may decrease the metabolism and clearance of Trimethoprim, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimethoprim if Piroxicam is initiated, discontinued or dose changed. [drugbank_resource:DB00440_DB00554]" assertion.
- drugbank_resource:DB00440_DB00554 identifier "drugbank_resource:DB00440_DB00554" assertion.
- drugbank_resource:DB00440_DB00554 title "DDI between Trimethoprim and Piroxicam - The strong CYP2C9 inhibitor, Piroxicam, may decrease the metabolism and clearance of Trimethoprim, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimethoprim if Piroxicam is initiated, discontinued or dose changed." assertion.
- drugbank:DB00554 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00440_DB00554 assertion.
- drugbank:DB00440 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00440_DB00554 assertion.